News

CVC Capital Partners Fund to acquire Therakos business from Mallinckrodt

Read time: 1 mins

Published:6th Aug 2024

Mallinckrodt plc, a global specialty pharmaceutical company, and CVC Capital Partners, one of the world's leading investment firms, announced that they have entered into a definitive agreement1 under which CVC Capital Partners Fund IX will acquire the Company's Therakos business for a purchase price of $925 million, subject to customary adjustments

Type: industry

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Industry news

Bayer introduces Age Factor ecosystem

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging space by offering consumers new tools to help them support their healthy-aging journey with its new Age Factor ecosystem

1 mins

Industry news

Bayer and NextRNA collaboration

Bayer and NextRNA Therapeutics have entered a strategic collaboration to develop small molecules targeting long non-coding RNAs (lncRNAs) for oncology treatments

1 min

Industry news

Johnson & Johnson to acquire V-Wave Ltd

Johnson & Johnson announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure

1 min

See all news